Breaking News Instant updates and real-time market news.

AMD

AMD

$11.47

-0.04 (-0.35%)

, X

U.S. Steel

$36.47

-0.34 (-0.92%)

07:35
12/22/16
12/22
07:35
12/22/16
07:35

Unusual call flow in option market yesterday

Notable call activity was cited Wednesday in AMD (AMD), US Steel (X), MGM Resorts (MGM), Cognizant (CTSH), Tesoro (TSO), Bed Bath & Beyond (BBBY), Silica Holdings (SLCA), Red Hat (RHT), Textron (TXT), and Imperva (IMPV).

AMD

AMD

$11.47

-0.04 (-0.35%)

X

U.S. Steel

$36.47

-0.34 (-0.92%)

MGM

MGM Resorts

$29.28

0.65 (2.27%)

CTSH

Cognizant

$56.28

-0.14 (-0.25%)

TSO

Tesoro

$89.67

0.9 (1.01%)

BBBY

Bed Bath & Beyond

$45.56

-0.64 (-1.39%)

SLCA

U.S. Silica

$55.54

1.8 (3.35%)

RHT

Red Hat

$79.79

0.4 (0.50%)

TXT

Textron

$48.70

0.04 (0.08%)

IMPV

Imperva

$38.90

0.7 (1.83%)

  • 15

    Jan

AMD AMD
$11.47

-0.04 (-0.35%)

12/20/16
12/20/16
UPGRADE
Target $13

Buy
AMD upgraded to Buy on deep learning and AI opportunity at Mizuho
As previously reported, Mizuho analyst Vijay Rakesh upgraded AMD (AMD) to Buy from Neutral, as he sees deep learning and AI as the next big computing paradigm and believes the company has an opportunity for deep learning with its new Radeon ProGFx/Ryzen products. He set a $13 price target on AMD shares. Rakesh, who said NVIDIA (NVDA) has solid traction in the initial Deep Learning space with GPUs and parallelism, raised his price target on its shares to $115 from $80, adding that while Intel (INTC) is a "late starter" and behind NVIDIA, it should also be a beneficiary of GPUs in the data center.
12/20/16
12/20/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly:1. NVIDIA (NVDA) upgraded to Conviction Buy from Buy at Goldman with analyst Toshiya Hari saying he expects AI/ML capacity additions to drive TAM expansion, high barriers of entry faced by competition and NVIDIA continues to leverage its position to gain greater share of the ML hardware TAM. 2. Carlyle Group (CG) upgraded to Buy from Neutral at Citi with analyst William Katz saying he expects a favorable FPAUM inflection into 2017, setting the stable for the next DE upcycle, and views valuation as compelling. 3. Alcoa (AA) upgraded to Outperform from Neutral at Macquarie saying it is the best way to participate in the pick up in global GDP and recommends using any weakness to build or initiate positions. 4. AMD (AMD) upgraded to Buy on deep learning and AI opportunity at Mizuho with analyst Vijay Rakesh saying he sees deep learning and Artificial Intelligence as the next big computing paradigm and believes the company has an opportunity for deep learning with its new Radeon ProGFx/Ryzen products. 5. Caterpillar (CAT) upgraded to Positive from Mixed at OTR Global with the firm saying its checks indicate the rate of decline in year-over-year global new equipment orders has moderated in Q4 due to strength in EMEA and Asia/Pacific. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/16
MZHO
12/20/16
UPGRADE
MZHO
Buy
AMD upgraded to Buy from Neutral at Mizuho
12/16/16
JEFF
12/16/16
NO CHANGE
Target $13
JEFF
Buy
AMD price target raised to $13 from $9 at Jefferies
Jefferies analyst Mark Lipacis raised his price target for AMD to $13 after his channel checks indicated the company's Zen MPU is being well received in the enthusiast DT channel. The analyst continues to believe AMD is in the midst of a turnaround. He raised his earnings estimates and reiterates a Buy rating on the stock.
X U.S. Steel
$36.47

-0.34 (-0.92%)

11/29/16
11/29/16
DOWNGRADE

On The Fly: Top five analyst downgrades
On The Fly: Top five analyst downgrades: 1. Wendy's (WEN) downgraded to Neutral from Buy at Goldman with analyst Karen Holthouse citing valuation with the stock up 23% over the past month. 2. SAIC (SAIC) downgraded to Neutral from Buy at Citi with analyst Jonathan Raviv citing the recent rally in the shares and some overhang from the pending contract transition. 3. BioMarin (BMRN), Johnson & Johnson (JNJ), and Vertex (VRTX) were downgraded to Equal Weight from Overweight at Barclays. 4. Nivalis Therapeutics (NVLS) downgraded to Market Perform Raymond James, to Hold from Buy at Stifel, to Market Perform from Outperform at Cowen, and to Neutral from Outperform at Baird. 5. U.S. Steel (X) downgraded to Hold from Buy at Argus. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/30/16
JPMS
11/30/16
NO CHANGE
JPMS
Overweight
JPMorgan raises targets for steel stocks on expected higher U.S. steel prices
JPMorgan analyst Michael Gambardella noted that ArcelorMittal (MT) raised its hot-rolled sheet pricing by $40 per ton, to $600 per ton, last night and he continues to think that supply cuts in the U.S. from both capacity curtailments and lower imports should support higher U.S. steel prices. The Trump administration's impact on trade could be "much quicker and more meaningful" than its infrastructure plans, said Gambardella, who raised his price targets on several stocks in the U.S. steel industry. He increased his target on AK Steel (AKS) to $11 from $8.50, on Nucor (NUE) to $70 from $59, on Steel Dynamics (STLD) to $41 from $31, on U.S. Steel (X) to $37 from $29 and on Cliffs Natural (CLF) to $10 from $7, while keeping Overweight ratings on all five stocks.
11/21/16
11/21/16
DOWNGRADE

Neutral
Follow-up: U.S. Steel downgraded on valuation, slowing auto growth at Rosenblatt
As previously reported, Rosenblatt downgraded U.S. Steel to Neutral from Buy. Analyst Chris Olin said shares appear fairly valued given recent share strength and reduced demand visibility and decelerating automotive growth.
11/29/16
ARGS
11/29/16
DOWNGRADE
ARGS
Hold
U.S. Steel downgraded to Hold from Buy at Argus
MGM MGM Resorts
$29.28

0.65 (2.27%)

12/20/16
AGIS
12/20/16
INITIATION
Target $35
AGIS
Buy
MGM Resorts initiated with a Buy at Aegis
Aegis analyst David Bain initiated MGM Resorts with a Buy and a $35 price target saying its Las Vegas position offers visible growth and upside to consensus estimates while its Macau exposure offers upside optionality.
12/15/16
GSCO
12/15/16
INITIATION
Target $37
GSCO
Buy
MGM Resorts initiated with a Buy at Goldman
Goldman analyst Stephen Grambling initiated MGM Resorts with a Buy and a $37 price target. Grambling said MGM will benefit from ongoing strength in Las Vegas and sees upside from sports, including the NHL team, Vegas Golden Knights, the potential addition of an NBA franchise in the future, and even the addition of an NFL franchise.
12/14/16
STFL
12/14/16
NO CHANGE
STFL
Macau outlook has improved, says Stifel
After conducting checks in Macau, Stifel analyst Steven Wieczynski says that casino operators appear to be much more upbeat about the market and its longer term outlook. The analyst is now much more bullish about the region's 2017 outlook. He adds that all of the operators with whom he spoke do not expect the change in UnionPay withdrawal limits to have a significant effect on their businesses. Wieczynski says that the casinos' non-VIP business remains healthy, while the VIP business could rebound more quickly than the market currently expects in 2017 . He keeps Buy ratings on Las Vegas Sands (LVS) and MGM (MGM) and a Hold rating on Wynn (WYNN). Melco Crown (MPEL) also owns casinos in Macau.
12/13/16
BERN
12/13/16
NO CHANGE
BERN
Checks show Macau GGR grew meaningfully this month, says Bernstein
Bernstein analyst Vitaly Umansky says the firm's checks indicate that from December 1-11 Macau's average daily gross gaming revenue rose 10% versus last month and about 20% versus the same period a year earlier. Umansky says that the region's December GGR is on track to jump 12%-14% year-over-year. However, he adds that breakdowns between VIP and non-VIP, along with market share data, are not available, causing him to be a bit skeptical about the data. Macau casino owners include Melco Crown (MPEL), Wynn Resorts (WYNN), Las Vegas Sands (LVS), and MGM Resorts (MGM). The analyst keeps an Outperform rating on Melco Crown.
CTSH Cognizant
$56.28

-0.14 (-0.25%)

11/23/16
WBLR
11/23/16
DOWNGRADE
WBLR
Market Perform
Cognizant downgraded to Market Perform from Outperform at William Blair
William Blair analyst Anil Doradla downgraded Cognizant Technology Solutions to Market Perform.
11/23/16
WBLR
11/23/16
DOWNGRADE
WBLR
Market Perform
Cognizant downgraded to Market Perform from Outperform at William Blair
William Blair analyst Anil Doradla downgraded Cognizant Technology Solutions to Market Perform from Outperform. After visiting India, the analyst is concerned that Cognizant will be affected by structural changes within the services industry. The newest headwind to the industry is related to the potential policy changes under President-elect Trump, Doradla tells investors in a research note. Further, the analyst is disappointed by the company's lack of capital returns to shareholders. He also expects Cognizant's growth will continue decelerating from 2016 through 2018. In pre-market trading, the shares are down 53c to $52.65.
11/30/16
JEFF
11/30/16
NO CHANGE
Target $63
JEFF
Buy
Elliott's involvement creates floor under Cognizant shares, says Jefferies
Jefferies analyst Jason Kupferberg said he believes Elliott Management's contention that Cognizant can drive its shares into the $80-$90 range is "potentially too optimistic," but he also thinks the activist's involvement creates a floor for shares "at a minimum" and he "whole-heartedly" agrees with the firm's capital deployment suggestions. Kupferberg keeps a Buy rating and $63 price target on Cognizant.
11/28/16
RHCO
11/28/16
NO CHANGE
RHCO
Hold
Cognizant small dividend seems achievable, says SunTrust
After Elliott Management disclosed a $1.4B position and released a letter to Cognizant Technology Solutions, SunTrust analyst Frank Atkins says he believes the company's major issue is not on the margin side but declining top line growth rates. A small dividend, as Elliott suggested, seems achievable and may fit with slightly lower top line trajectory going forward, Atkins tells investors in a research note. He continues to believe a Trump administration creates uncertainty and keeps a Hold rating on shares of Cognizant.
TSO Tesoro
$89.67

0.9 (1.01%)

10/11/16
FBCO
10/11/16
UPGRADE
FBCO
Outperform
Tesoro upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst Edward Westlake upgraded Tesoro to Outperform with a $100 price target.
12/12/16
WELS
12/12/16
UPGRADE
WELS
Outperform
Tesoro upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Roger Read upgraded Tesoro (TSO) to Outperform saying the outlook for refiners has become more positive following the recent presidential election and OPEC's production cuts. The analyst raised his price target range for the shares to $100-$105 from $90-$94. His top pick in the space remains Marathon Petroleum (MPC).
08/23/16
JEFF
08/23/16
INITIATION
Target $101
JEFF
Buy
Tesoro initiated with a Buy at Jefferies
Jefferies analyst Corey Goldman initiated Tesoro with a Buy rating and $101 price target, noting that the refiner's primary operating region is not plagued by excess product supplies unlike other U.S. markets.
11/18/16
RBCM
11/18/16
NO CHANGE
RBCM
Tesoro acquisition positive, says RBC Capital
RBC Capital analyst Brad Heffern says that Tesoro's (TSRO) acquisition of Western Refining (WNR) is positive for Tesoro, given the increased exposure that the latter company will have to the Permian as well as synergies it will achieve in the Southwest and Midwest. The analyst says that the deal should boost the company's EPS by 10%-18%, but he adds that this estimate could be conservative if Tesoro delivers on its synergy targets. He raised his price target on Tesoro to $87 from $84 but keeps a Sector Perform rating on the shares.
BBBY Bed Bath & Beyond
$45.56

-0.64 (-1.39%)

12/20/16
12/20/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Amgen (AMGN) downgraded to Neutral from Outperform at Credit Suisse with analyst Alethia Young saying she has a lower conviction in the base business and sees limited upside to positive PCSK9 outcomes in the first quarter of 2017 given high expectations. 2. Bed Bath & Beyond (BBBY) downgraded to Underperform from Neutral at Cleveland Research with analyst Daryl Boehringer citing checks that indicate comp trends remain "uninspiring" given declining traffic, online migration, lack of market share gains. 3. Sibanye Gold (SBGL) downgraded to Sell from Hold at Deutsche Bank with analyst Patrick Mann saying he expects a "challenging" 2017 for the company as EBITDA declines. 4. Cempra (CEMP) downgraded to Sell from Buy at SunTrust with analyst Edward Nash saying says he expects the FDA to provide complete response letters for the company's solithromycin treatment due to manufacturing issues. 5. Acuity Brands (AYI) downgraded to Neutral from Outperform at Baird with analyst Timothy Wojs saying he believes a near-term demand lull could keep the stock range bound over the next couple of quarters, leaving a thin margin for error. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/20/16
CLVD
12/20/16
DOWNGRADE
CLVD
Underperform
Bed Bath & Beyond downgraded to Underperform from Neutral at Cleveland Research
Cleveland Research analyst Daryl Boehringer downgraded Bed Bath & Beyond to Underperform following checks that indicate comp trends remain "uninspiring" given declining traffic, online migration, lack of market share gains. The analyst sees Q3 comps flat to slightly below consensus of +.4% and continues to see comp risk over the near-term and said it appears traffic has slowed noticeably over the last six weeks.
06/23/16
OPCO
06/23/16
NO CHANGE
OPCO
Perform
Bed Bath & Beyond continues to struggle, says Oppenheimer
Oppenheimer analyst Brian Nagel says Bed Bath & Beyond's weaker than expected Q1 results and more downbeat fiscal year 2016 outlook reflect ongoing struggles at the company. While the analyst remains optimistic that over the longer term Bed, Bath & Beyond will find the right formula to compete effectively online while protecting industry leading margins, he expects the current transition at the company to persist for a while and fuel choppiness in results. Nagel reiterates a Perform rating on the shares.
12/22/16
RAJA
12/22/16
DOWNGRADE
RAJA
Market Perform
Bed Bath & Beyond downgraded to Market Perform from Strong Buy at Raymond James
Raymond James analyst Budd Bugatch downgraded Bed Bath & Beyond to Market Perform from Strong Buy following the Q3 sales and earnings miss. The analyst said Bed Bath still has a long runway ahead before it realizes benefits from technology investments, membership program, and recent investments in One Kings Lane and PMall.com. Bugatch recommends moving to the sidelines until gross margins and operating expenses stabilize and the benefits of incremental investments are quantifiable.
SLCA U.S. Silica
$55.54

1.8 (3.35%)

12/02/16
COWN
12/02/16
NO CHANGE
Target $59
COWN
Outperform
U.S. Silica price target raised to $59 from $52 at Cowen
Cowen analyst Marc Bianchi raised his price target on U.S. Silica to $59 from $52 following its analyst day. The analyst believes the company's next acquisition will be focused on regional sand and with buying power at their disposal, the analyst sees an increase in EBITDA. Bianchi reiterated his Outperform rating on U.S. Silica shares.
12/16/16
GSCO
12/16/16
INITIATION
Target $67
GSCO
Buy
U.S. Silica initiated with a Buy at Goldman
Goldman analyst initiated U.S. Silica with a Buy and a $67 price target saying 2018 consensus estimates are too low, expected Frac sand demand, upside from the Sandbox acquisition, and its strong balance sheet is a key differentiator in the sector.
12/12/16
DADA
12/12/16
DOWNGRADE
DADA
Underperform
U.S. Silica downgraded to Underperform from Neutral at DA Davidson
12/12/16
DADA
12/12/16
DOWNGRADE
DADA
Underperform
U.S. Silica downgraded on valuation at DA Davidson
As noted earlier, DA Davidson downgraded U.S. Silica to Underperform from Neutral. Analyst Sonny Randhawa downgraded the stock based on valuation. Target $42.
RHT Red Hat
$79.79

0.4 (0.50%)

12/22/16
BMOC
12/22/16
DOWNGRADE
BMOC
Market Perform
Red Hat downgraded to Market Perform from Outperform at BMO Capital
11/28/16
11/28/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Johnson Controls (JCI) initiated with a Buy at Citi. 2. Red Hat (RHT) initiated with a Buy at Rosenblatt. 3. Ashland (ASH) reinstated with a Buy at Deutsche Bank. 4. MediWound (MDWD) initiated with a Buy at Aegis. 5. YY (YY) initiated with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/22/16
STFL
12/22/16
DOWNGRADE
Target $70
STFL
Hold
Red Hat downgraded to Hold from Buy at Stifel
Stiflel analyst Brad Reback downgraded Red Hat to Hold and lowered its price target to $70 from $87 citing the disappointing Q3 report. Billings growth of $679.4M grew only 8.7% year-over-year-CC, the lowest CC billings growth rate in at least 11 quarters, the analyst wrote. Reback is increasingly concerned that emerging areas of OpenStack and OpenShift are likely to remain niche products, combined with the "explosive" growth by hyperscale clout providers, is likely to limit Red Hat's future upside.
12/15/16
OTRG
12/15/16
NO CHANGE
OTRG
Red Hat re-sellers mostly met or exceeded Q3 expectations, says OTR Global
TXT Textron
$48.70

0.04 (0.08%)

10/28/16
VERT
10/28/16
INITIATION
Target $46
VERT
Buy
Textron initiated with a Buy at Vertical Research
Vertical Research analyst Robert Stallard initiated Textron with a Buy and a $46 price target.
06/23/16
06/23/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Amazon.com (AMZN), eBay (EBAY), and Groupon (GRPN) initiated with a Buy at Maxim. 2. Boeing (BA) initiated with an Overweight at Morgan Stanley. 3. Wal-Mart (WMT) coverage assumed with a Buy at Nomura. 4. Textron (TXT) initiated with an Underweight at Morgan Stanley. 5. ANI Pharmaceuticals (ANIP) initiated with a Strong Buy at Raymond James. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/14/16
COWN
12/14/16
NO CHANGE
Target $61
COWN
Outperform
Textron price target raised to $61 from $51 at Cowen
Cowen analyst Cai von Rumohr said Textron's defense operations "look flattish" through 2019, though he added that President-elect Trump's "buy smarter" approach to defense purchases may be more favorable than current policy to the company's self-financed Scorpion. Also, Trump's win looks positive for business jet demand, said von Rumohr, who raised his price target on Textron to $61 from $51 and keeps an Outperform rating on the shares.
10/06/16
BARD
10/06/16
INITIATION
Target $48
BARD
Outperform
Textron initiated with an Outperform at Baird
Baird analyst Peter.Arment initiated Textron with an Outperform and a $48 price target.
IMPV Imperva
$38.90

0.7 (1.83%)

11/04/16
11/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Imperva (IMPV) upgraded to Buy from Neutral at DA Davidson, to Outperform from Neutral at Macquarie, and to Buy from Neutral at DA Davidson. 2. 3D Systems (DDD) upgraded to Buy from Hold at Gabelli with analyst Hendi Susanto saying the company has reported progress in its turnaround initiatives and expects stronger sales, higher shipment, flat-to-slightly up operating expense and higher operating margin in the second-half compared to the first-half. 3. Global Payments (GPN) upgraded to Buy from Hold at Stifel analyst Christopher Brendler citing on and his belief that the company can realize significant revenue synergies from its acquisition of Heartland Payment (HPY). 4. Encana (ECA) upgraded to Outperform from Sector Perform at RBC Capital with analyst Greg Pardy saying the company's better than expected third quarter results "reinforce his confidence" in its ability to "deliver high margin oil and condensate growth from 2016-2021." 5. TrueCar (TRUE) upgraded to Buy from Hold at Loop Capital, to Buy from Hold at Craig-Hallum, and to Overweight from Equal Weight at Stephens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/04/16
SPHN
11/04/16
NO CHANGE
Target $53
SPHN
Overweight
Imperva price target lowered to $53 from $62 at Stephens
Stephens analyst Jonathan Ruykhaver lowered his price target for Imperva to $53 from $62 to reflect the tempered spend environment and uneven execution. The analyst reiterates an Overweight rating on the shares.
12/14/16
MSCO
12/14/16
INITIATION
Target $32
MSCO
Underweight
Imperva initiated with an Underweight at Morgan Stanley
Morgan Stanley initiated Imperva with an Underweight and a $32 price target.
11/04/16
DADA
11/04/16
UPGRADE
DADA
Buy
Imperva upgraded on Q3 results, margin outlook at DA Davidson
As noted earlier, DA Davidson upgraded Imperva to Buy from Neutral. Analyst Jack Andrews says that the company's q3 results indicate that its business fundamentals are "at least stabilizing," while its restructuring initiative could cause its margins to accelerate meaningfully. Target to $57 from $55.

TODAY'S FREE FLY STORIES

SPN

Superior Energy

$8.81

-0.14 (-1.56%)

21:18
11/20/17
11/20
21:18
11/20/17
21:18
Upgrade
Superior Energy rating change at SunTrust »

Superior Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$78.90

-0.59 (-0.74%)

, LOW

Lowe's

$81.46

1.24 (1.55%)

20:25
11/20/17
11/20
20:25
11/20/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$78.90

-0.59 (-0.74%)

LOW

Lowe's

$81.46

1.24 (1.55%)

ADI

Analog Devices

$93.07

2.65 (2.93%)

DLTR

Dollar Tree

$97.11

2.5 (2.64%)

HRL

Hormel Foods

$33.40

0.28 (0.85%)

CPB

Campbell Soup

$49.93

0.21 (0.42%)

BURL

Burlington Stores

$106.55

1.82 (1.74%)

SIG

Signet Jewelers

$75.84

-0.74 (-0.97%)

DSW

DSW

$22.53

0.38 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 21

    Nov

  • 27

    Nov

  • 01

    Dec

  • 07

    Dec

  • 08

    Dec

  • 09

    Jan

CCLP

CSI Compressco

$5.28

-0.16 (-2.94%)

19:32
11/20/17
11/20
19:32
11/20/17
19:32
Hot Stocks
CSI Compressco names Owen Serjeant president »

CSI Compressco announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAT

Applied Materials

$57.62

1.13 (2.00%)

, AAPL

Apple

$169.98

-0.17 (-0.10%)

19:04
11/20/17
11/20
19:04
11/20/17
19:04
Periodicals
Applied Materials expected to purchase former Apple complex, Mercury News says »

An office complex that…

AMAT

Applied Materials

$57.62

1.13 (2.00%)

AAPL

Apple

$169.98

-0.17 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

FOX

21st Century Fox

$29.90

-0.58 (-1.90%)

, FOXA

21st Century Fox

$30.66

-0.49 (-1.57%)

18:21
11/20/17
11/20
18:21
11/20/17
18:21
Periodicals
Fox reaches $90M settlement over sexual harassment scandal, Reuters says »

21st Century Fox reached…

FOX

21st Century Fox

$29.90

-0.58 (-1.90%)

FOXA

21st Century Fox

$30.66

-0.49 (-1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$188.00

2.87 (1.55%)

18:19
11/20/17
11/20
18:19
11/20/17
18:19
Hot Stocks
Muddy Waters says Alibaba numbers 'obviously fake' »

Short seller Muddy Waters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$142.53

-0.19 (-0.13%)

, CHKP

Check Point

$102.98

0.83 (0.81%)

18:15
11/20/17
11/20
18:15
11/20/17
18:15
Recommendations
Palo Alto Networks, Check Point, Fortinet analyst commentary at JPMorgan »

Palo Alto quarter…

PANW

Palo Alto Networks

$142.53

-0.19 (-0.13%)

CHKP

Check Point

$102.98

0.83 (0.81%)

FTNT

Fortinet

$40.77

0.46 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 07

    Dec

  • 11

    Dec

  • 11

    Dec

  • 17

    Jan

  • 17

    Jan

AMZN

Amazon.com

$1,126.31

-3.57 (-0.32%)

18:14
11/20/17
11/20
18:14
11/20/17
18:14
Hot Stocks
Amazon announces cloud software for U.S spy agencies AWS Secret Region »

Amazon announced the new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

BIVV

Bioverativ

$50.76

-5.35 (-9.53%)

, RHHBY

Roche

$30.82

1.72 (5.91%)

18:08
11/20/17
11/20
18:08
11/20/17
18:08
Recommendations
Deutsche cuts Bioverativ target to $53 after positive Roche data »

Deutsche Bank analyst…

BIVV

Bioverativ

$50.76

-5.35 (-9.53%)

RHHBY

Roche

$30.82

1.72 (5.91%)

SHPG

Shire

$141.37

-6 (-4.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Nov

  • 09

    Dec

  • 23

    Dec

  • 23

    Feb

CUBI

Customers Bancorp

$27.04

0.28 (1.05%)

18:04
11/20/17
11/20
18:04
11/20/17
18:04
Hot Stocks
Customers Bancorp: Flagship could raise capital in IPO transaction in 1H18 »

Customers Bancorp, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

18:04
11/20/17
11/20
18:04
11/20/17
18:04
Hot Stocks
AT&T CEO says has offered DOJ solutions that were not accepted »

Says DOJ suit throws lots…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

NGD

New Gold

$3.21

-0.02 (-0.62%)

18:02
11/20/17
11/20
18:02
11/20/17
18:02
Hot Stocks
New Gold announces sale of Peak Mines for $58M »

New Gold announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMI

Intermolecular

$1.31

0.1 (8.26%)

18:01
11/20/17
11/20
18:01
11/20/17
18:01
Hot Stocks
Intermolecular partners with SITRI to develop MtM technologies »

Intermolecular, Inc and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

CMCSA

Comcast

$35.83

-0.33 (-0.91%)

18:00
11/20/17
11/20
18:00
11/20/17
18:00
Initiation
Comcast initiated at Buckingham »

Comcast initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNX

Mellanox

$51.05

1 (2.00%)

17:59
11/20/17
11/20
17:59
11/20/17
17:59
Hot Stocks
Mellanox up nearly 6% after Starboard discloses a 9.8% stake in the company »

In after-hours trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 05

    Dec

  • 06

    Dec

PLNT

Planet Fitness

$30.15

0.07 (0.23%)

17:58
11/20/17
11/20
17:58
11/20/17
17:58
Initiation
Planet Fitness initiated at DA Davidson »

Planet Fitness initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$44.43

0.86 (1.97%)

17:57
11/20/17
11/20
17:57
11/20/17
17:57
Downgrade
Teradyne rating change at Deutsche Bank »

Teradyne downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

CBS

CBS

$55.93

-0.81 (-1.43%)

17:56
11/20/17
11/20
17:56
11/20/17
17:56
Periodicals
CBS News suspends Charlie Rose following sexual harassment claims, AP says 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$55.93

-0.81 (-1.43%)

17:55
11/20/17
11/20
17:55
11/20/17
17:55
Periodicals
Eight women accuse Charlie Rose of sexual harassment, Washington Post says »

Eight women have said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLNX

Mellanox

$51.05

1 (2.00%)

, MRVL

Marvell

$21.59

1.3 (6.41%)

17:53
11/20/17
11/20
17:53
11/20/17
17:53
Hot Stocks
Starboard Value reports 9.8% stake in Mellanox, may seek talks »

Peter A. Feld, a…

MLNX

Mellanox

$51.05

1 (2.00%)

MRVL

Marvell

$21.59

1.3 (6.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

CDXS

Codexis

17:46
11/20/17
11/20
17:46
11/20/17
17:46
Hot Stocks
Breaking Hot Stocks news story on Codexis »

Telemark Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

17:45
11/20/17
11/20
17:45
11/20/17
17:45
Hot Stocks
AT&T CEO says giving up control of CNN is a 'non-starter' »

Says plenty of solutions…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

BBY

Best Buy

$56.35

0.52 (0.93%)

17:45
11/20/17
11/20
17:45
11/20/17
17:45
Conference/Events
Best Buy management to meet with SunTrust »

Group dinner to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 20

    Nov

  • 21

    Nov

T

AT&T

$34.64

0.13 (0.38%)

, TWX

Time Warner

$87.71

-1.01 (-1.14%)

17:43
11/20/17
11/20
17:43
11/20/17
17:43
Hot Stocks
AT&T CEO says DOJ suit 'defies logic' »

Says has offered…

T

AT&T

$34.64

0.13 (0.38%)

TWX

Time Warner

$87.71

-1.01 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

RELY

Real Industry

$0.52

0.1643 (45.92%)

17:38
11/20/17
11/20
17:38
11/20/17
17:38
Hot Stocks
Real Industry, Real Alloy receive court approval of 'first day' motions »

Real Industry announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.